Clinical Trial of Shigella Vaccine Shows 89% Protection

Data ReadoutpositiveShigella VaccinePositive

AI Analysis

Summary

Cincinnati Children's researchers report positive data from a clinical trial of a Shigella vaccine demonstrating 89% protection against the disease. The trial represents progress toward developing a vaccine against a pathogen with significant global health implications.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

89% protection demonstrated in clinical trial

Importance:6/10

Sentiment:

0.75

vaccineclinical_trialshigellainfectious_diseasepositive_data

Related Companies

$GMRE-PA $HIT

Read the original article

Published by PR Newswire Biotech on July 1, 2026 3:30 PM

Read Original